Gender-Related Differences in Atrial Substrate in Patients with Atrial Fibrillation.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 09 2023
Historique:
received: 10 04 2023
revised: 23 06 2023
accepted: 29 06 2023
medline: 28 8 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

Gender-related differences have been reported in patients who underwent pulmonary vein isolation (PVI). Atrial substrate plays a role in the outcomes after ablation but gender-related differences in atrial substrate have never been described in detail. We sought to analyze gender-related differences in atrial remodeling (spontaneous low-voltage zones [LVZs]) and their clinical relevance after PVI. We conducted a prospective multicenter study, including consecutive patients who underwent first PVI-only atrial fibrillation (AF) ablation. LVZs were analyzed on high-density electroanatomical maps collected with multipolar catheter, before PVI. In total, 262 patients (61 ± 11 years, 31% female, 50% persistent AF) were followed for 28 months. In women, LVZs were larger (10% vs 4% of left atrial surface [p <0.001]) and female gender was independently associated with fourfold higher risk of having advanced (LVZ > 15%) atrial remodeling (odds ratio 4.56, p <0.001). AF recurrence-free survival was not different between men and women (log-rank p = 0.2). Although LVZs were independently associated higher AF recurrences at multivariate analysis (hazard ratio [HR] 1.2, p = 0.038), female gender was not (HR 1.4, p = 0.211). Specifically, the LVZ cutoff to predict outcomes was different in men and women: >5% in men (HR 3.0, p <0.001), >15% in women (HR 2.7, p = 0.02). In conclusion, women have more widespread LVZ in all left atrial regions. Despite more extensive atrial remodeling, the AF recurrence rate is similar in men and women, and LVZs become prognostic in women only at high burden (>15%). LVZs seem to have a different prognostic role in men and women.

Identifiants

pubmed: 37540903
pii: S0002-9149(23)00505-2
doi: 10.1016/j.amjcard.2023.06.095
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-458

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Auteurs

Olivier Van Leuven (O)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Marco Bergonti (M)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium; Division of Cardiology, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland. Electronic address: bergmar21@gmail.com.

Francesco Raffaele Spera (FR)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Teba Gonzalez Ferrero (TG)

Complexo Hospitalario Universitario de Santiago de Compostela (CHUS) SERGAS, Santiago de Compostela, Spain.

Michelle Nsahlai (M)

Department of Cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Giada Bilotta (G)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Maxime Tijskens (M)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Wim Boris (W)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Johan Saenen (J)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Wim Huybrechts (W)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Hielko Miljoen (H)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Jose Ramón González-Juanatey (JR)

Complexo Hospitalario Universitario de Santiago de Compostela (CHUS) SERGAS, Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV).

Jose Luis Martínez-Sande (JL)

Complexo Hospitalario Universitario de Santiago de Compostela (CHUS) SERGAS, Santiago de Compostela, Spain.

Lien Vandaele (L)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium.

Anouk Wittock (A)

Departments of Anesthesiology, University Hospital Antwerp, Antwerp, Belgium.

Hein Heidbuchel (H)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium; Departments of Anesthesiology, University Hospital Antwerp, Antwerp, Belgium.

Miguel Valderrábano (M)

Department of Cardiology, DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, Texas.

Moises Rodríguez-Mañero (M)

Complexo Hospitalario Universitario de Santiago de Compostela (CHUS) SERGAS, Santiago de Compostela, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV).

Andrea Sarkozy (A)

Departments of Cardiology, University Hospital Antwerp, Antwerp, Belgium; Cardiovascular Research, GENCOR, University of Antwerp, Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH